Atlas Trials

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.

RecordFirmDate
A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol (NCT03467113)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2018-01-19
A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome (NCT03355209)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2017-11-27
A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome (NCT03299842)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2017-07-12
A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome (NCT02926898)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2017-01-27
An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome (NCT02823145)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2016-06-08
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome (NCT02682927)Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2016-01-15

Track Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.